Enhanced B cell activation in the absence of CD81

International Immunology

Volumn 21, Issue 11, 2009, Pages 1225-1237

  Sanyal, Mrinmoy ^a   Fernandez, Rosemary ^a   Levy, Shoshana ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cell activation; Calcium mobilization; Knockout; Signal transduction; Tetraspanin; TLR4

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CD81 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE SYK; RAG1 PROTEIN; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CALCIUM CELL LEVEL; CONTROLLED STUDY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; ANTIGENS, T-INDEPENDENT; B-LYMPHOCYTES; CALCIUM; HOMEODOMAIN PROTEINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NF-KAPPA B; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; TOLL-LIKE RECEPTOR 4;

EID: 71049117164     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp090     Document Type: Article

References (55)

1. Seigneuret, M. 2006. Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: Conserved and variable structural domains in the tetraspanin superfamily. Biophys. J. 90:212.
2. Hemler, M. E. 2003. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 19:397.
3. Levy, S. and Shoham, T. 2005. The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 5:136.
4. Nydegger, S., Khurana, S., Krementsov, D. N., Foti, M. and Thali, M. 2006. Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. J. Cell Biol. 173:795.
5. Levy, S., Todd, S. C. and Maecker, H. T. 1998. CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16:89.
6. Pileri, P., Uematsu, Y., Campagnoli, S. et al. 1998. Binding of hepatitis C virus to CD81. Science 282:938.
7. Silvie, O., Rubinstein, E., Franetich, J. F. et al. 2003. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat. Med. 9:93.
8. Bradbury, L. E., Kansas, G. S., Levy, S., Evans, R. L. and Tedder, T. F. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149:2841.
9. Matsumoto, A. K., Martin, D. R., Carter, R. H., Klickstein, L. B., Ahearn, J. M. and Fearon, D. T. 1993. Functional dissection of the CD21/ CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178:1407.
10. Dempsey, P. W., Allison, M. E., Akkaraju, S., Goodnow, C. C. and Fearon, D. T. 1996. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity. Science 271:348.
11. Carter, R. H. and Fearon, D. T. 1992. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105.
12. Depoil, D., Fleire, S., Treanor, B. L. et al. 2008. CD19 is essential for B cell activation by promoting B cell receptor-antigen micro-cluster formation in response to membrane-bound ligand. Nat. Immunol. 9:63.
13. Rickert, R. C., Rajewsky, K. and Roes, J. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352.
14. Sato, S., Miller, A. S., Howard, M. C. and Tedder, T. F. 1997. Regulation of B lymphocyte development and activation by the CD19/CD21/ CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J. Immunol. 159:3278.
15. Wang, Y., Brooks, S. R., Li, X., Anzelon, A. N., Rickert, R. C. and Carter, R. H. 2002. The physiologic role of CD19 cytoplasmic tyrosines. Immunity 17:501.
16. Maecker, H. T. and Levy, S. 1997. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J. Exp. Med. 185:1505.
17. Miyazaki, T., Muller, U. and Campbell, K. S. 1997. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J. 16:4217.
18. Tsitsikov, E. N., Gutierrez-Ramos, J. C. and Geha, R. S. 1997. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc. Natl Acad. Sci. USA 94:10844.
19. van Zelm, M. C., Smet, J., Mascart, F. et al. 2008. Antibody-deficiency and acute nephritic syndrome in a patient with homozygous disruption of the CD81 gene. In: ASH Annual Meeting Abstracts. Blood 112:83.
20. Shoham, T., Rajapaksa, R., Boucheix, C. et al. 2003. The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment. J. Immunol. 171:4062.
21. Shoham, T., Rajapaksa, R., Kuo, C. C., Haimovich, J. and Levy, S. 2006. Building of the tetraspanin web: Distinct structural domains of CD81 function in different cellular compartments. Mol. Cell. Biol. 26:1373.
22. Masciopinto, F., Freer, G., Burgio, V. L. et al. 2002. Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection. Virology 304:187.
23. Sanyal, M., Tung, J. W., Karsunky, H. et al. 2007. B-cell development fails in the absence of the Pbx1 proto-oncogene. Blood 109:4191.
24. Krutzik, P. O., Clutter, M. R. and Nolan, G. P. 2005. Coordinate analysis of murine immune cell surface markers and intracellular phosphoproteins by flow cytometry. J. Immunol. 175:2357.
25. Di Virgilio, F., Steinberg, T. H. and Silverstein, S. C. 1990. Inhibition of Fura-2 sequestration and secretion with organic anion transport blockers. Cell Calcium 11:57.
26. Feske, S. 2007. Calcium signalling in lymphocyte activation and disease. Nat. Rev. Immunol. 7:690.
27. Scharenberg, A. M., Humphries, L. A. and Rawlings, D. J. 2007. Calcium signalling and cell-fate choice in B cells. Nat. Rev. Immunol. 7:778.
28. Andersson, J., Sjoberg, O. and Moller, G. 1972. Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur. J. Immunol. 2:349.
29. Miller, A. T., Sandberg, M., Huang, Y. H. et al. 2007. Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation. Nat. Immunol. 8:514.
30. Parker, D. C. 1993. T cell-dependent B cell activation. Annu. Rev. Immunol. 11:331.
31. Cariappa, A., Chase, C., Liu, H., Russell, P. and Pillai, S. 2007. Naive recirculating B cells mature simultaneously in the spleen and bone marrow. Blood 109:2339.
32. Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. and Hayakawa, K. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213.
33. Cariappa, A., Mazo, I. B., Chase, C. et al. 2005. Perisinusoidal B cells in the bone marrow participate in T-independent responses to blood-borne microbes. Immunity 23:397.
34. Cherukuri, A., Shoham, T., Sohn, H. W. et al. 2004. The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts. J. Immunol. 172:370.
35. Hardy, R. R. and Hayakawa, K. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595.
36. Li, Y. S., Wasserman, R., Hayakawa, K. and Hardy, R. R. 1996. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5:527.
37. van Zelm, M. C., Reisli, I., van der Burg, M. et al. 2006. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354:1901.
38. Kanegane, H., Agematsu, K., Futatani, T. et al. 2007. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun. 8:663.
39. Engel, P., Zhou, L. J., Ord, D. C., Sato, S., Koller, B. and Tedder, T. F. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39.
40. Fehr, T., Rickert, R. C., Odermatt, B. et al. 1998. Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J. Exp. Med. 188:145.
41. Pezzutto, A., Dorken, B., Rabinovitch, P. S., Ledbetter, J. A., Moldenhauer, G. and Clark, E. A. 1987. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J. Immunol. 138:2793.
42. Carter, R. H., Tuveson, D. A., Park, D. J., Rhee, S. G. and Fearon, D. T. 1991. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J. Immunol. 147:3663.
43. Fujimoto, M., Bradney, A. P., Poe, J. C., Steeber, D. A. and Tedder, T. F. 1999. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity 11:191.
44. Campbell, K. S. 1999. Signal transduction from the B cell antigen-receptor. Curr. Opin. Immunol. 11:256.
45. Deng, J., Dekruyff, R. H., Freeman, G. J., Umetsu, D. T. and Levy, S. 2002. Critical role of CD81 in cognate T-B cell interactions leading to Th2 responses. Int. Immunol. 14:513.
46. Maecker, H. T., Do, M. S. and Levy, S. 1998. CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses. Proc. Natl Acad. Sci. USA 95:2458.
47. Boismenu, R., Rhein, M., Fischer, W. H. and Havran, W. L. 1996. A role for CD81 in early T cell development. Science 271:198.
48. Conley, M. E., Rohrer, J., Rapalus, L., Boylin, E. C. and Minegishi, Y. 2000. Defects in early B-cell development: Comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Immunol. Rev. 178:75.
49. Wang, J. H., Avitahl, N., Cariappa, A. et al. 1998. Aiolos regulates B cell activation and maturation to effector state. Immunity 9:543.
50. O'Keefe, T. L., Williams, G. T., Davies, S. L. and Neuberger, M. S. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 274:798.
51. Otipoby, K. L., Andersson, K. B., Draves, K. E. et al. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384:634.
52. Sato, S., Miller, A. S., Inaoki, M. et al. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immunity 5:551.
53. Pan, C., Baumgarth, N. and Parnes, J. R. 1999. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. Immunity 11:495.
54. Xu, Y., Harder, K. W., Huntington, N. D., Hibbs, M. L. and Tarlinton, D. M. 2005. Lyn tyrosine kinase: Accentuating the positive and the negative. Immunity 22:9.
55. Tung, J. W., Parks, D. R., Moore, W. A., Herzenberg, L. A. and Herzenberg, L. A. 2004. Identification of B-cell subsets: An exposition of 11-color (Hi-D) FACS methods. Methods Mol. Biol. 271:37.